Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PharmaCool study in asphyxiated newborns during therapeutic hypothermia
NL-OMON34433Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jan 2011
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of Benzathine penicillin, amoxicillin, gentamicin, amikacin, vancomycin and 5 more in hypoxic-ischemic encephalopathy (HIE), asphyxia neonatorum, seizure and 1 more, sponsored by Amsterdam University Medical Center. Primary endpoints: Pharmacokinetic properties of study drugs, Seizure control and 5 more. Planned start Jan 2011; status: not yet recruiting.
02
Drugs
Benzathine penicillinamoxicillingentamicinamikacinvancomycin
03
Conditions
hypoxic-ischemic encephalopathy (HIE)asphyxia neonatorumseizurePerinatal infection
Beyond the preview
Go deeper on NL-OMON34433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34433.